Utilization of FibroScan in clinical practice

Current Gastroenterology Reports

Volumn 16, Issue 2, 2014, Pages

  Bonder, Alan ^a   Afdhal, Nezam ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cirrhosis; Liver fibrosis; Liver stiffness; Ultrasound elastography; Viral hepatitis

Indexed keywords

VIRUS RNA; ALANINE AMINOTRANSFERASE;

ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIGESTIVE TRACT PARAMETERS; ELASTOGRAPHY; ESOPHAGUS VARICES; FEASIBILITY STUDY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER FIBROSIS; LIVER STIFFNESS; MECHANICAL PROBE; MIXED INFECTION; MULTICENTER STUDY (TOPIC); NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; SENSITIVITY AND SPECIFICITY; SHEAR RATE; TRANSIENT ELASTOGRAPHY; ULTRASOUND SCANNER; VIBRATION; AREA UNDER THE CURVE; CHOLESTATIC HEPATITIS; CLINICAL EVALUATION; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPH; ECHOGRAPHY; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; UNITED STATES; FATTY LIVER; LIVER DISEASE; METHODOLOGY; PROFESSIONAL PRACTICE; PROGNOSIS; REVIEW; VIRUS HEPATITIS;

CHOLESTASIS, INTRAHEPATIC; COINFECTION; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; PROFESSIONAL PRACTICE; PROGNOSIS;

EID: 84895189927     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-014-0372-6     Document Type: Article

References (37)

1. Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49:1017-44.
2. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134(6):1670-8. (Pubitemid 351615414)
3. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-13. (Pubitemid 38091720)
4. Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828-35. A high BMI and obesity are factors that are associated with inaccurate LSM measurements.
5. Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411-2.
6. de Lédinghen V, Vergniol J, Foucher J, et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010;30:1043-8.
7. Friedrich-Rust M, Hadji-Hosseini H, Kriener S, et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol. 2010;20:2390-6.
8. Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012;107:1862-71. The XL probe is an important tool for patients with obesity and high BMI for accurate LSM measurements.
9. Pradhan F, Ladak F, Tracey J, et al. Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. Ann Hepatol. 2013;12:100-7.
10. Colli A, Pozzoni P, Berzuini A, et al. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;3:872-8.
11. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380-4. (Pubitemid 351280705)
12. Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592-5. (Pubitemid 351280727)
13. Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008;48:1718-23.
14. Tapper EB, Cohen EB, Patel K, et al. Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2012;10:932-7. Elevated liver tests in patients with early stage fibrosis may cause an increase in LSM measurements and should be considered as a variable that can falsely raise liver stiffness.
15. de Lédinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911-8. CAP with transient elastography is an accurate mode of measurement of liver steatosis and represents a novel additional benefit of the technology.
16. European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;1:167-85.
17. Lai M, Hyatt BJ, Nasser I, et al. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47:760-7. (Pubitemid 350051121)
18. Cardoso AC, Carvalho-Filho RJ, Stern C, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012;32:612-21.
19. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48-54. (Pubitemid 40066382)
20. Gara N, Zhao X, Kleiner DE, et al. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2013;11:303-8.
21. Malik R, Lai M, Sadiq A, et al. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol. 2010;25:1562-8.
22. Bonder A, Afdhal NH. Biopsy no more; changing the screening and diagnostic algorithm for hepatitis C. Clin Gastroenterol Hepatol. 2013;11:309-10.
23. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002;288:199-206. (Pubitemid 34755280)
24. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33:562-9. (Pubitemid 32709592)
25. Sánchez-Conde M, Montes-Ramírez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat. 2010;17:280-6.
26. Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118-24. (Pubitemid 43724636)
27. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274-85.
28. Arase Y, Suzuki F, Suzuki Y, et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology. 2009;49:739-44.
29. de Lédinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911-8.
30. Alkhouri N, Sedki E, Alisi A, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int. 2013;33:79-85.
31. Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27:1261-8. (Pubitemid 351697282)
32. Kazemi F, Kettaneh A, N'kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006;45:230-5.
33. Pritchett S, Cardenas A, Manning D, et al. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific. J Viral Hepat. 2011;18:e75-80.
34. Klibansky DA, Mehta SH, Curry M, et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat. 2012;19:e184-93. Transient elastography is a good tool to stratify high-risk patients with chronic liver disease and can predict risk of liver decompensation.
35. Cescon M, Colecchia A, Cucchetti A, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg. 2012;256:706-12.
36. Singh S, Fujii LL, Murad MH, et al. Liver Stiffness Measurements are Associated with Risk of Decompensation, Liver Cancer, and Death in Patients with Chronic Liver Diseases: a Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2013;15:S1542-3565.
37. Becker L, Salameh W, Sferruzza A, et al. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol. 2009;7:696-701.